Home
Trails Edge Capital Partners reported a 6.1% stake in Inhibikase Therapeutics IKT · 8,057,345 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 6.1%
- Last report
- 5.1% · filed 25/12/31
- Shares held
- 8,057,345 sh
- Class
- Common Stock, $0.001 par value
- Event date
- 26/03/31
- Filed
- 26/05/15
6.1% stake · +1.0pp from the last report
- Stake
- 6.1%
- Last report
- 5.1%
- Since last report
- +1.0pp
Inhibikase Therapeutics trades, last 26 weeks
What else happened in Inhibikase Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Trails Edge Capital Partners's other 5% stake reports
- Trails Edge Capital Partners
5% stakeFaeth Therapeutics
5% stakeFaeth Therapeutics
FTH
2% stake
515,335 sh
2% stake
Filed 08/14
- Trails Edge Capital Partners
5% stakeNeurogene
5% stakeNeurogene
NGNE
4.5% stake
714,885 sh
4.5% stake
Filed 08/14
- Trails Edge Capital Partners
5% stakeOnKure Therapeutics
5% stakeOnKure Therapeutics
OKUR
3.6% stake
1,438,456 sh
3.6% stake
Filed 08/14
- Trails Edge Capital Partners
5% stakeCamp4 Therapeutics
5% stakeCamp4 Therapeutics
CAMP
6% stake
3,790,636 sh
6% stake
Filed 08/10
- Trails Edge Capital Partners
5% stakeResearch Alliance Corp IV
5% stakeResearch Alliance Corp IV
RACD
5.5% stake
500,000 sh
5.5% stake
Filed 07/21
